Xylem Inc. (NYSE:XYL)‘s stock had its “hold” rating reaffirmed by equities research analysts at Stifel Nicolaus in a research note issued on Thursday, July 6th. They currently have a $52.00 price objective on the industrial products company’s stock. Stifel Nicolaus’ price objective indicates a potential downside of 7.31% from the company’s previous close.

Several other equities analysts have also recently weighed in on XYL. Goldman Sachs Group, Inc. (The) initiated coverage on shares of Xylem in a research note on Wednesday, March 8th. They set a “neutral” rating and a $52.00 target price for the company. Royal Bank Of Canada reaffirmed a “buy” rating and set a $57.00 target price on shares of Xylem in a research note on Sunday, March 12th. Cowen and Company raised their target price on shares of Xylem from $56.00 to $60.00 and gave the company an “outperform” rating in a research note on Friday, March 24th. Oppenheimer Holdings, Inc. set a $58.00 price objective on shares of Xylem and gave the stock a “buy” rating in a research note on Wednesday, April 5th. Finally, CIBC reaffirmed a “buy” rating and set a $58.00 price target on shares of Xylem in a research note on Thursday, April 6th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $56.85.

Xylem (XYL) traded up 0.47% during mid-day trading on Thursday, reaching $56.10. The company had a trading volume of 935,536 shares. Xylem has a one year low of $45.60 and a one year high of $56.18. The company has a market capitalization of $10.08 billion, a P/E ratio of 40.36 and a beta of 1.18. The stock has a 50 day moving average price of $53.05 and a 200 day moving average price of $50.40.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, May 2nd. The industrial products company reported $0.39 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.38 by $0.01. The company had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Xylem had a net margin of 6.75% and a return on equity of 15.53%. Xylem’s quarterly revenue was up 26.4% on a year-over-year basis. During the same period last year, the company posted $0.35 earnings per share. On average, equities analysts expect that Xylem will post $2.31 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 21st. Shareholders of record on Thursday, May 25th were given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 1.28%. The ex-dividend date was Tuesday, May 23rd. Xylem’s dividend payout ratio is presently 50.35%.

ILLEGAL ACTIVITY NOTICE: This piece was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/07/16/xylems-nysexyl-hold-rating-reaffirmed-at-stifel-nicolaus-updated.html.

In related news, Director Steven R. Loranger sold 66,132 shares of the business’s stock in a transaction on Thursday, June 29th. The shares were sold at an average price of $55.01, for a total value of $3,637,921.32. Following the completion of the transaction, the director now directly owns 65,030 shares in the company, valued at approximately $3,577,300.30. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Tomas Brannemo sold 14,080 shares of the business’s stock in a transaction on Thursday, May 4th. The shares were sold at an average price of $50.36, for a total transaction of $709,068.80. Following the completion of the transaction, the insider now owns 21,000 shares of the company’s stock, valued at $1,057,560. The disclosure for this sale can be found here. 0.75% of the stock is owned by corporate insiders.

A number of institutional investors have recently bought and sold shares of XYL. Peoples Financial Services CORP. boosted its position in Xylem by 3.2% in the first quarter. Peoples Financial Services CORP. now owns 6,463 shares of the industrial products company’s stock worth $324,000 after buying an additional 200 shares in the last quarter. Bank of America Corp DE boosted its position in Xylem by 4.2% in the first quarter. Bank of America Corp DE now owns 2,251,684 shares of the industrial products company’s stock worth $113,079,000 after buying an additional 91,478 shares in the last quarter. Toronto Dominion Bank boosted its position in Xylem by 56.6% in the first quarter. Toronto Dominion Bank now owns 48,431 shares of the industrial products company’s stock worth $2,433,000 after buying an additional 17,497 shares in the last quarter. Asset Planning Services Ltd. boosted its position in Xylem by 0.3% in the first quarter. Asset Planning Services Ltd. now owns 2,107 shares of the industrial products company’s stock worth $106,000 after buying an additional 7 shares in the last quarter. Finally, Teachers Advisors LLC boosted its position in Xylem by 23.1% in the fourth quarter. Teachers Advisors LLC now owns 242,609 shares of the industrial products company’s stock worth $12,014,000 after buying an additional 45,505 shares in the last quarter. Institutional investors own 85.28% of the company’s stock.

About Xylem

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Stock Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related stocks with our FREE daily email newsletter.